❄️💉 𝗡𝗘𝗫𝗧-𝗚𝗘𝗡 𝗖𝗥𝗬𝗢 𝗗𝗥𝗨𝗚 𝗗𝗘𝗟𝗜𝗩𝗘𝗥𝗬: 𝗦𝗖𝗛𝗢𝗧𝗧 𝗧𝗢𝗣𝗣𝗔𝗖® -𝟭𝟴𝟬°𝗖 𝗦𝗬𝗥𝗜𝗡𝗚𝗘

Discover a revolutionary leap in cryogenic drug delivery with SCHOTT TOPPAC® Freeze Prefillable Polymer Syringes — the first of their kind to withstand ultra-low temperatures down to -180°C. This cutting-edge innovation sets a new standard for storing and delivering sensitive biologics, cell and gene therapies, and cryotherapies.

In this video, we explore:

Why this syringe is a game-changer for advanced therapy medicinal products (ATMPs)

The $5B+ market opportunity in ultra-cold chain biologic logistics

How SCHOTT's innovation compares to cryobags

Integration potential with CDMOs, logistics providers, and biopharma leaders

Strategic M&A and investment outlook

🎯 Whether you're in biotech, medtech, pharma innovation, or VC investment, this technology marks a major milestone in drug delivery and biomedicine.

👉 Like, subscribe, and comment with your thoughts on the future of cryogenic drug delivery.
#CryogenicSyringes #CellTherapy #GeneTherapy #Biologics #BiotechInnovation #SCHOTTPharma #Cryopreservation #DrugDelivery #PharmaPackaging #MedicalDevices #ColdChainLogistics #ATMP #HealthcareInnovation #Biopharma #MergersAndAcquisitions #MedicalTechnology #GMP #CDMO #4DCryobioprinting #MedTech

Видео ❄️💉 𝗡𝗘𝗫𝗧-𝗚𝗘𝗡 𝗖𝗥𝗬𝗢 𝗗𝗥𝗨𝗚 𝗗𝗘𝗟𝗜𝗩𝗘𝗥𝗬: 𝗦𝗖𝗛𝗢𝗧𝗧 𝗧𝗢𝗣𝗣𝗔𝗖® -𝟭𝟴𝟬°𝗖 𝗦𝗬𝗥𝗜𝗡𝗚𝗘 канала AI Biopharma Playbook